Evidence map›Paper›PMID 39147875›Full record

ArticleScientific reports2024

Feasibility of magnetomyography with optically pumped magnetometers in a mobile magnetic shield.

Simon Nordenström, Victor Lebedev, Stefan Hartwig, Marlen Kruse, Justus Marquetand, Philip Broser, Thomas Middelmann

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. High-Resolution Atomic Magnetometer-Based Imaging of Integrated Circuits and Batteries.IEEE transactions on instrumentation and measurement · 2026
    Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Simon NordenströmPhysikalisch-Technische Bundesanstalt, 10587, Berlin, Germany. simon.nordenstroem@ptb.de.
Victor LebedevPhysikalisch-Technische Bundesanstalt, 10587, Berlin, Germany.
Stefan HartwigPhysikalisch-Technische Bundesanstalt, 10587, Berlin, Germany.
Marlen KrusePhysikalisch-Technische Bundesanstalt, 10587, Berlin, Germany.
Justus MarquetandHertie Institute for Clinical Brain Research, University of Tübingen, 72076, Tübingen, Germany.
Philip BroserOstschweizer Kinderspital, 9006, Sankt Gallen, Switzerland.
Thomas MiddelmannPhysikalisch-Technische Bundesanstalt, 10587, Berlin, Germany.

Funding

Deutsches Zentrum für Luft- und Raumfahrt DLR 50WM2168
6 · The paper itself

Abstract

While magnetomyography (MMG) using optically pumped magnetometers (OPMs) is a promising method for non-invasive investigation of the neuromuscular system, it has almost exclusively been performed in magnetically shielded rooms (MSRs) to date. MSRs provide extraordinary conditions for biomagnetic measurements but limit the widespread adoption of measurement methods due to high costs and extensive infrastructure. In this work, we address this issue by exploring the feasibility of mobile OPM-MMG in a setup of commercially available components. From field mapping and simulations, we find that the employed zero-field OPM can operate within a large region of the mobile shield, beyond which residual magnetic fields and perturbations become increasingly intolerable. Moreover, with digital filtering and moderate averaging a signal quality comparable to that in a heavily shielded MSR is attained. These findings facilitate practical and cost-effective implementations of OPM-MMG systems in clinical practice and research.

Indexed as

BiomagnetismFEM simulationsMagnetic shieldsNon-invasive muscle measurementsQuSpin QZFM Gen. 3Twinleaf MS-2

Identifiers

PMID39147875
PMCPMC11327291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.